Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Short term Debt (2020 - 2025)

Agilon Health's Short term Debt history spans 6 years, with the latest figure at $19.2 million for Q4 2025.

  • For Q4 2025, Short term Debt changed N/A year-over-year to $19.2 million; the TTM value through Dec 2025 reached $19.2 million, changed N/A, while the annual FY2025 figure was $19.2 million, N/A changed from the prior year.
  • Short term Debt reached $19.2 million in Q4 2025 per AGL's latest filing, down from $35.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $35.0 million in Q3 2025 to a low of $3.8 million in Q2 2021.
  • Average Short term Debt over 5 years is $11.5 million, with a median of $5.0 million recorded in 2021.
  • Peak YoY movement for Short term Debt: changed 0.0% in 2022, then soared 365.65% in 2025.
  • A 5-year view of Short term Debt shows it stood at $5.0 million in 2021, then changed by 0.0% to $5.0 million in 2022, then increased by 25.0% to $6.2 million in 2023, then soared by 40.0% to $8.8 million in 2024, then skyrocketed by 119.86% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Short term Debt are $19.2 million (Q4 2025), $35.0 million (Q3 2025), and $34.9 million (Q2 2025).